Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SULFASALAZINE
- Sulfasalazine in Patients With Metastatic Colorectal Cancer
- Topical Sulfasalazine and Oral Lichen Planus
- The Effect of Sulfasalazine on CRH Levels in Pregnant Women
- The Effect of Cilostazol on Rheumatoid Arthritis Patients
- Glutamate Inhibitors in Glioblastoma
- Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
- A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
- The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
- Drug-drug Interaction Study With GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
- A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677
- Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
- Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA
- Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
- Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
- Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification
- Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin
- Psoriatic Oligoarthritis Intervention With Symptomatic thErapy
- Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
- Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
- Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis
- Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums
- Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis
- Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy
- Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active D
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
- Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
- Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).
- Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
- Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
- An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan i
- Very Early Versus Delayed Etanercept in Patients With RA
- Treatments Against RA and Effect on FDG-PET/CT
- A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
- Combination Therapy Prevents the Relapse of RA
- An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
- Patients Response to Early Switch To Oral:Osteomyelitis Study
- To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
- Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial
- Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
- Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
- A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine
- Study of Sulfasalazine in Treating Painful Neuropathy
- Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection
- Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
- A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy
- Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects
- Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.
- Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
- Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash
- Effects of Sulfasalazine on BOLD Response to Alcohol Cues
- Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
- Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
- Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
- A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
- TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis
- Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis
- Curcumin in Pediatric Inflammatory Bowel Disease
- Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
- Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)
- The Colitis Once Daily Asacol Study
- Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis
- A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis
- Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis
- Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
- Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies
- Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
- Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis
- Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
- Sulfasalazine and Endothelial Function
- Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
- Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy
- Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
- A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
- Methotrexate in the Treatment of Axial Spondyloarthritis
- Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
- Methotrexate in Ankylosing Spondylitis (MTX in AS)
- Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
- Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
- CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission
- Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
- Monoclonal Antibody Treatment of Crohn's Disease
- Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis
- Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
- Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy
- A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis
Clinical trials list
click for details